{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:18:50Z","timestamp":1787811530679,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>IgA vasculitis nephritis (IgAVN) is the principal cause of morbidity and mortality in children with IgA vasculitis (IgAV),the pathogenesis of the renal injury and predictive biomarkers are still unclear. In this study, we performed an integrated untargeted and targeted metabolomics to identify candidate biomarkers and explore oxidative stress-related alterations associated with IgAVN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum samples were collected from 115 IgAV and 111 IgAVN children. We conducted untargeted metabolomics for preliminary screening of potential biomarkers on 50 IgAV and 50 IgAVN children and then performed validation experiments based on targeted LC-MS\/MS on 65 IgAV and 61 IgAVN children. In addition, an IgAVN animal model was established to preliminarily verify oxidative stress-related alterations associated with key metabolic abnormalities by assessing the levels of GSH, GSH\/GSSG, MDA, 4-HNE, NRF2, HO-1, and GPX4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 45 differential metabolites were identified between the IgAV and IgAVN groups, including 23 upregulated and 22 downregulated metabolites, which were mainly enriched in glutathione metabolism, pyruvate metabolism, the citrate cycle, sphingolipid metabolism, and steroid hormone biosynthesis. Further targeted validation confirmed that six metabolites, including sphinganine, dehydroepiandrosterone, kynurenine, glutathione, nervonic acid, and creatine differed significantly between the two groups. The combined model based on these six metabolites showed good discriminatory performance, with an AUC of 0.903 and an area under the PRC curve of 0.909. In the animal experiments, the model group exhibited decreased GSH levels, a disrupted GSH\/GSSG balance, increased MDA and 4-HNE levels, as well as abnormal expression of NRF2, HO-1, and GPX4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children with IgAVN exhibit a distinct metabolic profile characterized by glutathione depletion, activation of inflammation-related tryptophan metabolism, lipid\/membrane remodeling, and disordered energy metabolism. Sphinganine, dehydroepiandrosterone, kynurenine, glutathione, nervonic acid, and creatine may serve as potential biomarkers for IgAVN, and the combined model based on these metabolites showed good discriminatory ability and potential clinical utility. The consistency between the clinical metabolomics findings and the experimental evidence supports supports glutathione-related oxidative stress and the GSH-NRF2\/HO-1\/GPX4 axis as candidate pathways associated with IgAVN-related renal injury. These findings provide a basis for early risk identification and future mechanistic and pharmacological investigations in pediatric IgAVN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1886454","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:39:46Z","timestamp":1787809186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated untargeted and targeted metabolomics combined with experimental validation reveal glutathione-related oxidative stress in pediatric IgA vasculitis nephritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Leying","family":"Xi","sequence":"first","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Xu","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionqiong","family":"Xing","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Sun","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Liu","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Ren","sequence":"additional","affiliation":[{"name":"Pediatric Hospital of The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pediatrics, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1523-1755.2003.00152.x","article-title":"Oxidative stress and kidney dysfunction due to ischemia\/reperfusion in rat: attenuation by dehydroepiandrosterone","volume":"64","author":"Aragno","year":"2003","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e15961","DOI":"10.14814\/phy2.15961","article-title":"NRF2 in kidney physiology and disease","volume":"12","author":"Bondi","year":"2024","journal-title":"Physiol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1677\/joe.0.1660401","article-title":"Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells","volume":"166","author":"Brignardello","year":"2000","journal-title":"J. Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12519-014-0534-5","article-title":"Henoch-Schonlein purpura nephritis in children: incidence, pathogenesis and management","volume":"11","author":"Chen","year":"2015","journal-title":"World J. Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.semarthrit.2020.09.006","article-title":"Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis","volume":"50","author":"Demir","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"117561","DOI":"10.1016\/j.cca.2023.117561","article-title":"Altered serum metabolic profile in patients with IgA nephropathy","volume":"549","author":"Dong","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10238-019-00580-9","article-title":"Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome","volume":"19","author":"Han","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.3390\/ijms262110449","article-title":"Ferroptosis in autoimmune diseases: research advances and therapeutic strategies","volume":"26","author":"He","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.ekir.2024.07.020","article-title":"N-acetylcysteine in kidney disease: molecular mechanisms, pharmacokinetics, and clinical effectiveness","volume":"9","author":"Hernandez-Cruz","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1681\/ASN.2015070772","article-title":"Sigma1-receptor agonism protects against renal ischemia-reperfusion injury","volume":"28","author":"Hosszu","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12964-023-01422-8","article-title":"Role of ferroptosis in chronic kidney disease","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.3390\/ijms26157471","article-title":"NRF2 dysregulation and therapeutic insights across chronic kidney diseases","volume":"26","author":"Lim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0265017","DOI":"10.1371\/journal.pone.0265017","article-title":"Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning","volume":"17","author":"Lin","year":"2022","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"114537","DOI":"10.1016\/j.intimp.2025.114537","article-title":"Mesenchymal stromal cells reduce ferroptosis of podocytes by activating the Nrf2\/HO-1\/GPX4 pathway in lupus nephritis","volume":"153","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103340","DOI":"10.1016\/j.redox.2024.103340","article-title":"Role of mitochondria in reno-cardiac diseases: a study of bioenergetics, biogenesis, and GSH signaling in disease transition","volume":"76","author":"Lumpuy-Castillo","year":"2024","journal-title":"Redox Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2174\/1389557522666220919125817","article-title":"Dehydroepiandrosterone (DHEA): pharmacological effects and potential therapeutic application","volume":"23","author":"Nenezic","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatol. Oxf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e943912","DOI":"10.12659\/MSM.943912","article-title":"A review of IgA Vasculitis (Henoch-Schonlein purpura) past, present, and future","volume":"30","author":"Parums","year":"2024","journal-title":"Med. Sci. Monit."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1038\/s41598-025-87228-9","article-title":"GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN","volume":"15","author":"Qing","year":"2025","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3390\/jcm13175050","article-title":"Sphingolipids and chronic kidney disease","volume":"13","author":"Sakic","year":"2024","journal-title":"J. Clin. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell."},{"key":"B24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis","volume":"40","author":"Vivarelli","year":"2025","journal-title":"Pediatr. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1778919","DOI":"10.3389\/fphar.2026.1778919","article-title":"The biological basis of Blood-heat syndrome in children with Henoch-Schonlein purpura nephritis: a multidimensional analysis based on clinical proteomics and an animal model","volume":"17","author":"Xu","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00431-024-05573-9","article-title":"Exploring potential predictors of Henoch-Schonlein purpura nephritis: a pilot investigation on urinary metabolites","volume":"183","author":"Yu","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s43440-021-00329-w","article-title":"Kynurenine pathway in kidney diseases","volume":"74","author":"Zakrocka","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e70492","DOI":"10.1096\/fj.202403111R","article-title":"Construction and diagnostic efficacy assessment of the urinary exosomal miRNA-mRNA network in children with IgA vasculitis nephritis","volume":"39","author":"Zhang","year":"","journal-title":"FASEB J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1737456","DOI":"10.3389\/fcell.2025.1737456","article-title":"Glutathione peroxidase 4 as an emerging therapeutic target in osteoarthritis: focus on ferroptosis","volume":"13","author":"Zhang","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e15786","DOI":"10.7717\/peerj.15786","article-title":"Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins","volume":"11","author":"Zhao","year":"2023","journal-title":"PeerJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1626324","DOI":"10.3389\/fmed.2025.1626324","article-title":"Biomarker research for Henoch-Schonlein purpura nephritis based on \u201comics\u201d techniques","volume":"12","author":"Zhou","year":"2025","journal-title":"Front. Med. (Lausanne)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1886454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:39:47Z","timestamp":1787809187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1886454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":32,"alternative-id":["10.3389\/fphar.2026.1886454"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1886454","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1886454"}}